Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

June 11, 1998

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

Crambescidin 816, an antiviral and antitumor agent from a marine sponge

June 10, 1998

AHP reports dopamine autoreceptor agonists with antipsychotic potential

June 10, 1998

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

June 9, 1998

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

Perimidine-based CRF antagonists developed at Agouron

June 9, 1998

BMS prepares novel sulfenamide taxane derivatives

June 9, 1998

Procter & Gamble R&D on metalloprotease inhibition

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...